2H-Indol-2-one, 1,3-dihydro-3-(2-pyridinylmethylene)-, (3Z)- manufacturers
|
| | 2H-Indol-2-one, 1,3-dihydro-3-(2-pyridinylmethylene)-, (3Z)- Basic information |
| Product Name: | 2H-Indol-2-one, 1,3-dihydro-3-(2-pyridinylmethylene)-, (3Z)- | | Synonyms: | 2H-Indol-2-one, 1,3-dihydro-3-(2-pyridinylmethylene)-, (3Z)-;GSK-3β inhibitor 1;GSK-3,inhibit,Glycogen synthase kinase 3,Glycogen synthase kinase-3,GSK3β inhibitor 1,GSK-3β inhibitor 1,Inhibitor,GSK 3β inhibitor 1;(Z)-3-(Pyridin-2-ylmethylene)indolin-2-one;(3Z)-3-(2-pyridinylmethylene)-1,3-dihydro-2H-indol-2-one | | CAS: | 187325-53-7 | | MF: | C14H10N2O | | MW: | 222.24 | | EINECS: | | | Product Categories: | | | Mol File: | 187325-53-7.mol |  |
| | 2H-Indol-2-one, 1,3-dihydro-3-(2-pyridinylmethylene)-, (3Z)- Chemical Properties |
| Boiling point | 457.2±45.0 °C(Predicted) | | density | 1.291±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | Soluble in DMSO | | pka | 12.34±0.20(Predicted) | | form | Solid | | color | Yellow to orange | | InChI | InChI=1S/C14H10N2O/c17-14-12(9-10-5-3-4-8-15-10)11-6-1-2-7-13(11)16-14/h1-9H,(H,16,17)/b12-9- | | InChIKey | YKQONSWBHGBDSB-XFXZXTDPSA-N | | SMILES | N1C2=C(C=CC=C2)/C(=C/C2=NC=CC=C2)/C1=O |
| | 2H-Indol-2-one, 1,3-dihydro-3-(2-pyridinylmethylene)-, (3Z)- Usage And Synthesis |
| Uses | GSK-3β inhibitor 1 (compound 3a) inhibits GSK-3β with an IC50 of 4.19 nM. GSK-3β inhibitor 1 demonstrates high antidiabetic efficacy in obese Streptozotocin (HY-13753)-treated rats[1]. | | in vivo | GSK-3β inhibitor 1 (50 mg/kg, i.p., 30 min prior to glucose challenge) effectively prevents increase in blood glucose levels in HFD+STZ diabetic rats[1].
| Animal Model: | HFD+STZ diabetic rats [1] . | | Dosage: | 50 mg/kg | | Administration: | i.p., 30 min prior to glucose challenge | | Result: | Vehicle-treated diabetic rats developed persistent hyperglycemic response. Administration of GSK-3β inhibitor 1 30 min prior to glucose challenge effectively prevented increase in blood glucose levels.
|
| | IC 50 | GSK-3β: 4.9 nM (IC50) | | References | [1] Lozinskaya NA, et al. Synthesis and biological evaluation of 3-substituted 2-oxindole derivatives as new glycogen synthase kinase 3β inhibitors. Bioorg Med Chem. 2019 May 1;27(9):1804-1817. DOI:10.1016/j.bmc.2019.03.028 |
| | 2H-Indol-2-one, 1,3-dihydro-3-(2-pyridinylmethylene)-, (3Z)- Preparation Products And Raw materials |
|